ImClone’s Sam Waksal: Out of Jail and Doing Biotech Deals Again
After five years behind bars for insider trading, Waksal has announced another biotech deal: His new drug company Kadmon Pharmaceuticals has bought privately held Three Rivers Pharmaceuticals in a private deal estimated at over…